Pulmonary function tests (PFTs) are essential diagnostic tools in respiratory medicine, providing valuable insights into lung function. However, interpreting these results can be complex. This article aims to provide a comprehensive guide to assist healthcare professionals in understanding and interpreting PFT results.
Spirometry measures the volume and speed of breath, providing data on Forced Vital Capacity (FVC) and Forced Expiratory Volume in one second (FEV1). The FEV1/FVC ratio is critical for diagnosing obstructive and restrictive lung diseases. A ratio less than 0.7 suggests obstructive disease, while a normal or high ratio with reduced FVC indicates restrictive disease.
The Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) assesses gas exchange across the alveolar-capillary membrane. A reduced DLCO may indicate interstitial lung disease, pulmonary hypertension, or emphysema. Correcting DLCO for alveolar volume (VA) can help differentiate between diseases.
Static lung volumes, including Total Lung Capacity (TLC), Residual Volume (RV), and Functional Residual Capacity (FRC), can be informative. An increased RV or FRC may suggest air trapping, common in obstructive diseases. Flow-volume loops provide insights into upper airway obstruction and extrathoracic intrathoracic diseases.
Cardiopulmonary exercise testing (CPET) evaluates the respiratory, cardiovascular, and skeletal muscle systems' integrated response to exercise. It can help identify the cause of unexplained dyspnea and assess fitness for surgery.
Interpreting PFT results is a complex but essential skill for healthcare professionals. A thorough understanding of spirometry, gas diffusion capacity, volume measurements, flow rates, and exercise testing can aid in accurate diagnosis and effective patient management. Continuous education and practice are key to mastering this skill.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation